These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 22753698)
1. Effects of (5Z)-7-oxozeaenol on MDA-MB-231 breast cancer cells. Acuña UM; Wittwer J; Ayers S; Pearce CJ; Oberlies NH; DE Blanco EJ Anticancer Res; 2012 Jul; 32(7):2415-21. PubMed ID: 22753698 [TBL] [Abstract][Full Text] [Related]
2. Effects of (5Z)-7-oxozeaenol on the oxidative pathway of cancer cells. Acuña UM; Wittwer J; Ayers S; Pearce CJ; Oberlies NH; DE Blanco EJ Anticancer Res; 2012 Jul; 32(7):2665-71. PubMed ID: 22753724 [TBL] [Abstract][Full Text] [Related]
3. Synergistic action of 5Z-7-oxozeaenol and bortezomib in inducing apoptosis of Burkitt lymphoma cell line Daudi. Zhang J; Li B; Wu H; Ou J; Wei R; Liu J; Cai W; Liu X; Zhao S; Yang J; Zhou L; Liu S; Liang A Tumour Biol; 2016 Jan; 37(1):531-9. PubMed ID: 26227222 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of hyperthermia-induced apoptosis by 5Z-7-oxozeaenol, a TAK1 inhibitor, in A549 cells. Li P; Zhao QL; Jawaid P; Rehman MU; Sakurai H; Kondo T Cell Stress Chaperones; 2016 Sep; 21(5):873-81. PubMed ID: 27448221 [TBL] [Abstract][Full Text] [Related]
5. TAK1 inhibitor 5Z-7-oxozeaenol sensitizes cervical cancer to doxorubicin-induced apoptosis. Guan S; Lu J; Zhao Y; Woodfield SE; Zhang H; Xu X; Yu Y; Zhao J; Bieerkehazhi S; Liang H; Yang J; Zhang F; Sun S Oncotarget; 2017 May; 8(20):33666-33675. PubMed ID: 28430599 [TBL] [Abstract][Full Text] [Related]
6. Celecoxib induced apoptosis against different breast cancer cell lines by down-regulated NF-κB pathway. Wang G; Li J; Zhang L; Huang S; Zhao X; Zhao X Biochem Biophys Res Commun; 2017 Aug; 490(3):969-976. PubMed ID: 28666869 [TBL] [Abstract][Full Text] [Related]
7. Mechanism and in vitro pharmacology of TAK1 inhibition by (5Z)-7-Oxozeaenol. Wu J; Powell F; Larsen NA; Lai Z; Byth KF; Read J; Gu RF; Roth M; Toader D; Saeh JC; Chen H ACS Chem Biol; 2013 Mar; 8(3):643-50. PubMed ID: 23272696 [TBL] [Abstract][Full Text] [Related]
8. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo. Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135 [TBL] [Abstract][Full Text] [Related]
9. Disruption of thioredoxin metabolism enhances the toxicity of transforming growth factor β-activated kinase 1 (TAK1) inhibition in KRAS-mutated colon cancer cells. Hrabe JE; O'Leary BR; Fath MA; Rodman SN; Button AM; Domann FE; Spitz DR; Mezhir JJ Redox Biol; 2015 Aug; 5():319-327. PubMed ID: 26114584 [TBL] [Abstract][Full Text] [Related]
10. TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy. Fan Y; Cheng J; Vasudevan SA; Patel RH; Liang L; Xu X; Zhao Y; Jia W; Lu F; Zhang H; Nuchtern JG; Kim ES; Yang J Apoptosis; 2013 Oct; 18(10):1224-34. PubMed ID: 23700229 [TBL] [Abstract][Full Text] [Related]
11. Indole-3-carbinol-induced modulation of NF-kappaB signalling is breast cancer cell-specific and does not correlate with cell death. Moiseeva EP; Heukers R Breast Cancer Res Treat; 2008 Jun; 109(3):451-62. PubMed ID: 17653853 [TBL] [Abstract][Full Text] [Related]
12. A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase. Ninomiya-Tsuji J; Kajino T; Ono K; Ohtomo T; Matsumoto M; Shiina M; Mihara M; Tsuchiya M; Matsumoto K J Biol Chem; 2003 May; 278(20):18485-90. PubMed ID: 12624112 [TBL] [Abstract][Full Text] [Related]
13. The apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways. Maroufi NF; Vahedian V; Akbarzadeh M; Mohammadian M; Zahedi M; Isazadeh A; Pouremamali F; Taefehshokr S; Heidari M; Rashidi M; Nouri M Breast Cancer; 2020 Jul; 27(4):613-620. PubMed ID: 32026267 [TBL] [Abstract][Full Text] [Related]
14. [Stellera chamaejasme against multidrug resistance of triple-negative breast cancer MDA-MB-231 cell through Nrf2]. Zeng R; Wang XX; Cui XH; Yang Q; Zhu XX; Wang YJ Zhongguo Zhong Yao Za Zhi; 2024 Apr; 49(8):2222-2229. PubMed ID: 38812237 [TBL] [Abstract][Full Text] [Related]
15. Atiprimod triggered apoptotic cell death via acting on PERK/eIF2α/ATF4/CHOP and STAT3/NF-ΚB axis in MDA-MB-231 and MDA-MB-468 breast cancer cells. Coker-Gurkan A; Can E; Sahin S; Obakan-Yerlikaya P; Arisan ED Mol Biol Rep; 2021 Jun; 48(6):5233-5247. PubMed ID: 34244887 [TBL] [Abstract][Full Text] [Related]
16. TGFβ-activated Kinase 1 (TAK1) Inhibition by 5Z-7-Oxozeaenol Attenuates Early Brain Injury after Experimental Subarachnoid Hemorrhage. Zhang D; Yan H; Li H; Hao S; Zhuang Z; Liu M; Sun Q; Yang Y; Zhou M; Li K; Hang C J Biol Chem; 2015 Aug; 290(32):19900-9. PubMed ID: 26100626 [TBL] [Abstract][Full Text] [Related]
17. Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-κB activity via the Notch-1 pathway. Pan H; Zhou W; He W; Liu X; Ding Q; Ling L; Zha X; Wang S Int J Mol Med; 2012 Aug; 30(2):337-43. PubMed ID: 22580499 [TBL] [Abstract][Full Text] [Related]
18. PCI-24781 induces caspase and reactive oxygen species-dependent apoptosis through NF-kappaB mechanisms and is synergistic with bortezomib in lymphoma cells. Bhalla S; Balasubramanian S; David K; Sirisawad M; Buggy J; Mauro L; Prachand S; Miller R; Gordon LI; Evens AM Clin Cancer Res; 2009 May; 15(10):3354-65. PubMed ID: 19417023 [TBL] [Abstract][Full Text] [Related]
19. Anti-Proliferation and Pro-Apoptotic Effects of Diosmetin via Modulating Cell Cycle Arrest and Mitochondria-Mediated Intrinsic Apoptotic Pathway in MDA-MB-231 Cells. Wang C; Li S; Ren H; Sheng Y; Wang T; Li M; Zhou Q; He H; Liu C Med Sci Monit; 2019 Jun; 25():4639-4647. PubMed ID: 31228347 [TBL] [Abstract][Full Text] [Related]
20. CD24 enhances DNA damage-induced apoptosis by modulating NF-κB signaling in CD44-expressing breast cancer cells. Ju JH; Jang K; Lee KM; Kim M; Kim J; Yi JY; Noh DY; Shin I Carcinogenesis; 2011 Oct; 32(10):1474-83. PubMed ID: 21798852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]